Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CTR20210970Phase 2Completed
A Phase 2 trial of dexlipotam tromethamine in diabetic polyneuropathy (DPN), sponsored by Nanjing Hairong Pharmaceutical Technology. Started May 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on CTR20210970.